Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V C Jordan

Showing results (241-250 of 365) with videos related to

Pageof 37
Sort By:
Breast Cancer Research and Treatment|January 1, 1987
Estrogenic effects of phenolphthalein on human breast cancer cells in vitroP M Ravdin, M van Beurden, V C Jordan
Cancer Research|August 1, 1986
Determination of estrogen receptor in breast cancer using monoclonal antibody technology: results of a multicenter study in the United StatesV C Jordan, H I Jacobson, E J Keenan
European Journal of Cancer & Clinical Oncology|December 1, 1989
Implications of tamoxifen metabolism in the athymic mouse for the study of antitumor effects upon human breast cancer xenograftsS P Robinson, S M Langan-Fahey, V C Jordan
The Journal of Endocrinology|November 1, 1977
A monohydroxylated metabolite of tamoxifen with potent antioestrogenic activityV C Jordan, M M Collins, L Rowsby, et al.
Molecular and Cellular Endocrinology|April 1, 1977
Studies on the mechanism of action of the nonsteroidal antioestrogen tamoxifen (I.C.I. 46,474) in the ratV C Jordan, C J Dix, L Rowsby, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
Tamoxifen metabolites in patients on long-term adjuvant therapy for breast cancerS M Langan-Fahey, D C Tormey, V C Jordan
Cancer Letters|May 24, 2000
Effects of angiogenesis inhibitor TNP-470 on tamoxifen-stimulated MCF-7 breast tumors in nude miceH Takei, E S Lee, A Cisneros, et al.
European Journal of Cancer|May 1, 1979
The mode of action of the antitumour agent GP 48,989 in the ratV C Jordan, B Dixon, G Prestwich, et al.
European Journal of Cancer (Oxford, England : 1990)|August 1, 1996
A realistic clinical perspective of tamoxifen and endometrial carcinogenesisV J Assikis, P Neven, V C Jordan, et al.
British Journal of Pharmacology|January 1, 1986
Oestrogenic and antioestrogenic actions in a series of triphenylbut-1-enes: modulation of prolactin synthesis in vitroV C Jordan, R Koch, S Mittal, et al.
Pageof 37

Showing results (241-250 of 365) with videos related to

Sort By:
Pageof 37
Breast Cancer Research and Treatment|January 1, 1987
Estrogenic effects of phenolphthalein on human breast cancer cells in vitroP M Ravdin, M van Beurden, V C Jordan
Cancer Research|August 1, 1986
Determination of estrogen receptor in breast cancer using monoclonal antibody technology: results of a multicenter study in the United StatesV C Jordan, H I Jacobson, E J Keenan
European Journal of Cancer & Clinical Oncology|December 1, 1989
Implications of tamoxifen metabolism in the athymic mouse for the study of antitumor effects upon human breast cancer xenograftsS P Robinson, S M Langan-Fahey, V C Jordan
The Journal of Endocrinology|November 1, 1977
A monohydroxylated metabolite of tamoxifen with potent antioestrogenic activityV C Jordan, M M Collins, L Rowsby, et al.
Molecular and Cellular Endocrinology|April 1, 1977
Studies on the mechanism of action of the nonsteroidal antioestrogen tamoxifen (I.C.I. 46,474) in the ratV C Jordan, C J Dix, L Rowsby, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
Tamoxifen metabolites in patients on long-term adjuvant therapy for breast cancerS M Langan-Fahey, D C Tormey, V C Jordan
Cancer Letters|May 24, 2000
Effects of angiogenesis inhibitor TNP-470 on tamoxifen-stimulated MCF-7 breast tumors in nude miceH Takei, E S Lee, A Cisneros, et al.
European Journal of Cancer|May 1, 1979
The mode of action of the antitumour agent GP 48,989 in the ratV C Jordan, B Dixon, G Prestwich, et al.
European Journal of Cancer (Oxford, England : 1990)|August 1, 1996
A realistic clinical perspective of tamoxifen and endometrial carcinogenesisV J Assikis, P Neven, V C Jordan, et al.
British Journal of Pharmacology|January 1, 1986
Oestrogenic and antioestrogenic actions in a series of triphenylbut-1-enes: modulation of prolactin synthesis in vitroV C Jordan, R Koch, S Mittal, et al.
Pageof 37